Virtual Reality Exposure Therapy (VRET) in Psychomotor Disadaptation Syndrome
Launched by HOPITAL NORD FRANCHE-COMTE · Mar 18, 2025
Trial Information
Current as of April 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with PMDS
- • Ability to stand without human or technical assistance
- • Falls Efficacy Scale International Short (FES-I short) \> 13
- • Functional Reach Test (FRT) score \< 26 cm
- • Mini-Mental State Examination (MMSE) score ≥ 20
- Exclusion Criteria:
- • Patients with disorders that may interfere with immersion in virtual reality (e.g. cerebellar syndromes, Parkinsonian syndromes, hallucinations, sensory or neurocognitive disorders)
- • Cybermalaise or cyberkinetosis
About Hopital Nord Franche Comte
Hospital Nord Franche-Comté is a leading healthcare institution located in the Franche-Comté region of France, dedicated to providing high-quality medical care and advancing clinical research. With a strong emphasis on innovation and patient-centered services, the hospital collaborates with various stakeholders to conduct clinical trials that aim to enhance treatment options and improve health outcomes. Its multidisciplinary team of healthcare professionals and researchers is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of trial results while prioritizing patient safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trevenans, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
